Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy

subject category

Biochemistry & Molecular Biology; Cell Biology


Almeida, CR; Ferreira, BH; Duarte, IF

our authors


C.R.A. and I.F.D. are supported, respectively, by iBiMED - Institute of Biomedicine (UIDB/04501/2020) and CICECO - Aveiro Institute of Materials (UIDB/50011/2020 & UIDP/50011/2020), financed by national funds through the Foundation for Science and Technology (FCT)/MCTES. B.H.F. is supported by FCT through an individual grant (SFRH/BD/144706/2019).

Share this project:

Related Publications

We use cookies for marketing activities and to offer you a better experience. By clicking “Accept Cookies” you agree with our cookie policy. Read about how we use cookies by clicking "Privacy and Cookie Policy".